Carregant...

SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetes

The prevalence of type 2 diabetes mellitus (T2DM) is rising in Australia. Sodium glucose co-transporter 2 (SGLT2) inhibitors are an emerging treatment for T2DM. SGLT2 inhibitors offer a novel approach to lowering hyperglycaemia by suppressing renal glucose reabsorption and increasing urinary glucose...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Australas Med J
Autors principals: Moses, Robert G, Colagiuri, Stephen, Pollock, Carol
Format: Artigo
Idioma:Inglês
Publicat: Australasian Medical Journal 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221776/
https://ncbi.nlm.nih.gov/pubmed/25379062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4066/AMJ.2014.2181
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!